Description: untitled123

 

                                                                                     April 06, 2015

 

Press Release No. 1

Clarification by Sujana Tower Limited

 

Significant price movement has been observed in Sujana Tower Limited.

 

The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company.

 

Sujana Tower Limited has vide its letter inter-alia stated, "The Company is complying all the relevant clauses of the listing agreement in respect of the disclosures/intimations from time to time and also confirming that, as of now, there is no specific event/announcement/price sensitive information in the Company, which is required to be disclosed with the Stock Exchanges as per the listing agreement and have a bearing on the price behavior in the scrip."

 

 

Press Release No. 2

Clarification by Arvind Remedies Limited

 

Significant price movement has been observed in Arvind Remedies Limited.

 

The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company.

 

Arvind Remedies Limited has vide its letter inter-alia stated, "The Company has been so far complying with all the listing requirements including furnishing information as per Clause 36 that were having bearing on the operations/ performance of the company. As regards the recent price increase, it is hereby clarified we are not aware of any new information or event with us as reason for the same."

 

 

Press Release No. 3

Clarification by Parabolic Drugs Limited

 

Significant price movement has been observed in Parabolic Drugs Limited.

 

The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company.

 

Parabolic Drugs Limited has vide its letter inter-alia stated, "We have to submit that as on date, there exists no information as is required to be furnished to the Stock Exchange in terms of Clause 36 of the Listing Agreement."